Hepatosplenomegaly in Pediatric Age: Case Discussion & Key Points
Model Case Presentation
Patient Demographics
Name: Master Arjun, Age: 3 years, Gender: Male, Informant: Mother (Reliable)
Chief Complaints
- Swelling of abdomen – 6 months
- Pallor noticed by mother – 4 months
- Recurrent fever – 2 months
- Decreased activity and easy fatigability – 1 month
History Summary
A 3-year-old male child presented with progressively increasing abdominal distension, pallor, and recurrent low-to-moderate grade fever without a definite pattern. Mother noticed the child tires easily during play and has had progressive reduction in appetite. Child has had no vomiting of blood, no black stools, no jaundice, no dark-coloured urine. No squatting, no puffiness of face. There is a history of two prior blood transfusions at another hospital (suggesting chronic haemolytic anaemia). Elder sibling also has similar illness with pallor and abdominal swelling — strongly suggesting a familial/hereditary condition.
Born at term via NVD. Birth weight 3.1 kg. Received all immunizations up to date. Parents are consanguineous (first cousins) — raises suspicion of autosomal recessive conditions (thalassaemia, storage disorders, hereditary spherocytosis).
Examination Summary
| Parameter | Finding | Significance |
|---|---|---|
| Weight | 10.5 kg (below 3rd centile) | Failure to Thrive |
| Height | 85 cm (below 3rd centile) | Stunting (chronic illness) |
| Pallor | Severe (all mucous membranes) | Chronic haemolytic anaemia |
| Icterus | Mild | Haemolysis |
| Cyanosis / Clubbing | Absent | — |
| Facies | Frontal bossing, prominent malar eminences, flat nasal bridge | Thalassaemia facies (chipmunk facies) |
| Liver | 6 cm below RCM, firm, non-tender, smooth surface | Hepatomegaly (haematopoiesis/iron overload) |
| Spleen | Crosses umbilicus (Hackett Grade IV) | Massive Splenomegaly |
| Lymph nodes | Not enlarged | Argues against malignancy |
| Ascites | Absent | — |
Bone tenderness: Present over skull and long bones (extramedullary haematopoiesis). Hair-on-end appearance anticipated on skull X-ray.
Cardiovascular: Tachycardia. Flow murmur (hyperdynamic circulation due to anaemia). No features of cardiac failure.
✅ Complete Diagnosis
Beta Thalassaemia Major — with Hepatosplenomegaly (due to extramedullary haematopoiesis and haemosiderosis), Severe Anaemia, Failure to Thrive, and Thalassaemia Facies.
Differential Diagnoses to Exclude: Kala-azar (Visceral Leishmaniasis), Malaria (chronic), Portal Hypertension (EHPVO), Leukemia, Gaucher's disease.
📝 History — Exam Q&A
Hepatomegaly: Liver edge palpable more than 3.5 cm below the right costal margin (RCM) in neonates, and more than 2 cm below RCM in older children. More reliably assessed by liver span (percussion to palpation in mid-clavicular line).
Splenomegaly: Spleen is not normally palpable beyond infancy. Any palpable spleen beyond 6 months of age is considered abnormal. Note: The spleen must be approximately 2–3 times its normal size before it becomes palpable.
Normal liver span by age (clinical percussion):
| Age | Mean Liver Span |
|---|---|
| Neonate | ~4.5–5.5 cm |
| 1 year | ~5.5–6.5 cm |
| 6 years | ~6–7 cm |
| 12 years (female) | ~6–6.5 cm |
| 12 years (male) | ~7–8 cm |
| Category | Examples |
|---|---|
| Infections (most common overall) | Malaria, Kala-azar (visceral leishmaniasis), Typhoid, Septicemia, TB (miliary), EBV, CMV, Congenital TORCH, Brucellosis, Leptospirosis, HIV |
| Haematological | Thalassaemia major, Sickle cell disease, Hereditary spherocytosis, Autoimmune haemolytic anaemia, Leukemia, Lymphoma |
| Vascular/Congestive | Congestive cardiac failure (CCF), Portal hypertension (EHPVO, cirrhosis), Constrictive pericarditis, Budd-Chiari syndrome |
| Storage Disorders | Gaucher's disease, Niemann-Pick disease, Glycogen storage diseases (Type I, III, IV), Mucopolysaccharidoses (Hurler's) |
| Tumours/Infiltrative | Leukemia (ALL, CML), Lymphoma, Neuroblastoma, Hepatoblastoma |
| Miscellaneous | Juvenile idiopathic arthritis (Still's), SLE, Sarcoidosis, Osteopetrosis, Haemophagocytic lymphohistiocytosis (HLH) |
| Mechanism | Examples |
|---|---|
| Increased cell size (cellular hypertrophy) | Glycogen/lipid storage disorders (Gaucher, Niemann-Pick, GSD) |
| Increased cell number (hyperplasia) | Infections (increased RES activity), Haemolytic anaemias, Extramedullary haematopoiesis |
| Vascular engorgement / congestion | CCF, Portal hypertension, Budd-Chiari |
| Infiltration | Leukemia, Lymphoma, Amyloidosis, Histiocytosis |
| Biliary obstruction | Biliary atresia, choledochal cyst (mainly hepatomegaly) |
| Inflammation | Hepatitis, Abscess |
| Age Group | Common Causes |
|---|---|
| Neonates / Early Infancy | TORCH infections, Congenital syphilis, Haemolytic disease of newborn (Rh/ABO), Biliary atresia, Galactosaemia, Neonatal hepatitis, Storage disorders |
| Infancy (1–12 months) | Thalassaemia major, Sickle cell disease, Storage disorders, Malignancy (leukaemia), Congenital infections |
| 1–5 years | Thalassaemia major, Malaria, Kala-azar, ALL, Gaucher's disease, Portal hypertension |
| Older children | Hereditary spherocytosis, JIA (Still's disease), Lymphoma, Cirrhosis, Wilson's disease, Chronic malaria/kala-azar |
| Symptom / History Clue | Diagnosis to Consider |
|---|---|
| Fever with rigors, cyclical pattern, travel to endemic area | Malaria |
| Prolonged fever, weight loss, epistaxis, exposure to sandfly-endemic area | Kala-azar (Visceral Leishmaniasis) |
| Stepladder fever, rose spots, relative bradycardia | Typhoid |
| Recurrent jaundice, pallor, need for transfusions, family history | Thalassaemia, Hereditary spherocytosis |
| Haematemesis, malena, dilated abdominal veins | Portal hypertension (oesophageal varices) |
| H/O umbilical catheterisation or neonatal sepsis | Extrahepatic portal vein obstruction (EHPVO) |
| Bone pain, pallor, bleeding, night sweats, lymphadenopathy | Leukaemia / Lymphoma |
| Delayed milestones, neurological regression, consanguineous parents | Storage disorders (Gaucher, Niemann-Pick) |
| Breathlessness, pedal oedema, poor feeding in infancy | Congestive cardiac failure |
| Arthritis, rash, fever | JIA (systemic), SLE |
- No haematemesis/malena — rules out bleeding varices from portal hypertension
- No jaundice/dark urine/clay-coloured stools — rules out obstructive or haemolytic jaundice
- No prolonged jaundice at birth — rules out biliary atresia, galactosaemia, congenital infections
- No umbilical catheterisation in neonatal period — rules out EHPVO
- No transfusion history — rules out Hepatitis B/C, haemolytic anaemias
- No neurological regression / loss of milestones — rules out storage disorders (Niemann-Pick, Gaucher Type 3)
- No travel to endemic region — rules out malaria, kala-azar
- No TB contact / BCG scar / Mantoux history — rules out miliary TB
- No family history of consanguinity / similar illness in siblings — helps assess recessive conditions
The terminology reflects which organ is predominantly enlarged:
- Hepatosplenomegaly — liver enlargement is predominant (liver disease, congestive, storage).
- Splenohepatomegaly — spleen enlargement is predominant (chronic haemolysis, kala-azar, portal hypertension, CML).
The pattern of predominance is an important clinical clue. For example, massive splenomegaly with mild hepatomegaly points strongly towards kala-azar, chronic malaria, thalassaemia, EHPVO, or storage disorders. A predominantly enlarged liver with mild splenomegaly suggests hepatic pathology (hepatitis, biliary disease, metabolic liver disease, hepatic malignancy).
Massive splenomegaly is defined as spleen crossing the umbilicus (Hackett Grade IV–V, or spleen palpable >8 cm below LCM). Mnemonic: KATT MSG
- Kala-azar (Visceral leishmaniasis)
- Acute/chronic Malaria (tropical splenomegaly)
- Thalassaemia major
- TB (miliary / disseminated)
- Myeloproliferative disorders (CML)
- Spherocytosis (hereditary), Sickle cell
- Gaucher's disease
- Extrahepatic portal vein obstruction (EHPVO)
- Osteopetrosis
- Hairy cell leukaemia (rare in children)
🩺 Examination — Exam Q&A
- Position: Child supine, knees slightly flexed to relax abdominal muscles. Start from the right iliac fossa (never start near the RCM — you may miss a very large liver).
- Move hand upward with each expiration, pressing gently. Feel for the lower liver edge descending against the fingers during inspiration.
- Note: distance below RCM in mid-clavicular line, surface (smooth/nodular), edge (sharp/rounded), consistency (soft/firm/hard), tenderness.
- Confirm with percussion — measure liver span from upper border (dullness to percussion in mid-clavicular line) to lower border (palpation or dullness to percussion).
💡 Important
A palpable liver does NOT always mean hepatomegaly. Thin children, low-lying liver (Riedel's lobe), hyperinflated lungs (asthma/bronchiolitis) can all push the liver down. Always confirm with liver span.
Technique: Start palpation from the right iliac fossa and move diagonally toward the left hypochondrium. The spleen enlarges along its long axis toward the right iliac fossa. Ask the patient to take a deep breath — the splenic notch (medial border) may be felt descending. Place patient in right lateral decubitus if not palpable supine.
Distinguishing features of spleen from other masses: Cannot get above it, notch on medial border, moves with respiration (inferomedially), dull to percussion, not bimanually ballotable (unlike kidney).
Hackett's Grading of Splenomegaly:
| Grade | Description |
|---|---|
| Grade 0 | Not palpable even on deep inspiration |
| Grade I | Palpable below costal margin on deep inspiration only |
| Grade II | Palpable below costal margin on normal breathing |
| Grade III | Extends to umbilical level |
| Grade IV | Extends below umbilicus but not to iliac fossa |
| Grade V | Extends into right iliac fossa / beyond |
| Feature | Spleen | Left Kidney | Stomach/Colon mass |
|---|---|---|---|
| Can get above mass | No | Sometimes | Yes |
| Notch | Present (medial) | Absent | Absent |
| Moves with respiration | Yes (inferomedially) | Yes (inferiorly) | Variable |
| Percussion | Dull | Resonant (bowel in front) or Dull | Variable |
| Ballottable | No | Yes (bimanually) | No |
| Band of colonic resonance | Absent | Present | — |
| Finding | Diagnosis Suggested |
|---|---|
| Severe pallor + icterus + splenomegaly | Haemolytic anaemia (thalassaemia, spherocytosis) |
| Thalassaemia facies (frontal bossing, malar prominence, flat nose) | Thalassaemia major |
| Pallor + petechiae/purpura + lymphadenopathy | Leukaemia, Lymphoma |
| Prolonged fever + cachexia + no lymphadenopathy + darkening of skin (post kala-azar dermal leishmaniasis) | Kala-azar |
| Jaundice + spider naevi + caput medusae + ascites | Chronic liver disease / Portal hypertension |
| Kayser-Fleischer rings + neurological signs | Wilson's disease |
| Hepatosplenomegaly + cherry-red spot on macula | Niemann-Pick disease Type A, GM1 gangliosidosis, Tay-Sachs (HSM less common in Tay-Sachs) |
| Joint swelling + rash + high fever (quotidian) + HSM | Systemic JIA (Still's disease) |
| Increased JVP + hepatomegaly + pedal oedema | Congestive cardiac failure |
| Bone pain + pallor + massive HSM | Gaucher's disease, Leukaemia |
Stigmata of chronic liver disease seen in children (also in adults):
- Jaundice, icterus
- Spider angiomata (> 5 in distribution of SVC territory)
- Palmar erythema
- Leukonychia (white nails), Terry's nails
- Clubbing (in cirrhosis and biliary disease)
- Caput medusae (dilated periumbilical veins) — portal hypertension
- Ascites
- Gynecomastia (older children/adolescents)
- Asterixis (liver flap) — hepatic encephalopathy
- Xanthomas — in cholestatic liver disease
Differences in children: Parotid enlargement and Dupuytren's contracture are less common. Growth retardation and rickets (fat-soluble vitamin deficiency) are more prominent in paediatric chronic liver disease.
Hypersplenism is a syndrome characterized by:
- Splenomegaly
- Peripheral cytopenias (anaemia, leukopenia, thrombocytopenia — one or more)
- Cellular (compensatory hyperplastic) bone marrow
- Improvement (correction of cytopenias) after splenectomy
The enlarged spleen sequesters and destroys blood cells in excess. The most common cause of hypersplenism in children is portal hypertension (EHPVO, cirrhosis).
- Splenomegaly (most reliable early sign)
- Caput medusae — dilated tortuous periumbilical veins radiating outward (direction of flow is away from the umbilicus — distinguishes from IVC obstruction where flow is upward)
- Ascites — shifting dullness, fluid thrill
- Haematemesis / Malena — from oesophageal/gastric varices
- Hepatomegaly — variable; may be small in cirrhosis, large in EHPVO
- Splenorenal or other collateral veins
- Haemorrhoids (older children)
💡 EHPVO vs Cirrhosis in Portal Hypertension
In EHPVO (extrahepatic portal vein obstruction): liver is normal sized or mildly enlarged, liver function tests are normal, splenomegaly is massive. In cirrhosis: liver is small and firm (shrunken), LFTs are deranged, ascites more prominent.
Traube's space is a semilunar area of gastric resonance in the left lower anterior chest, bounded by:
- Superiorly — lower border of the left lung
- Medially — left lobe of the liver
- Laterally/inferiorly — left costal margin
Normally resonant due to the stomach's air bubble. Dullness in Traube's space indicates splenomegaly (spleen has filled the space), left pleural effusion, or a full stomach. It is a quick screening test for splenomegaly by percussion before attempting to palpate. A positive Traube's (dullness) has sensitivity of ~62% and specificity ~72% for splenomegaly.
🔬 Investigations — Exam Q&A
- Complete Blood Count (CBC) + Peripheral Blood Smear (PBS) — most important initial investigation
- Liver Function Tests (LFTs) — ALT, AST, ALP, GGT, bilirubin (total + direct), albumin, PT/INR
- Reticulocyte count — elevated in haemolytic anaemias
- ESR — elevated in infections, malignancy, connective tissue diseases
- Ultrasonography (USG) Abdomen with Doppler — confirm organ size, echogenicity, portal vein flow, ascites, lymph nodes
- Urine routine/microscopy
- Blood culture + Widal test (if fever present)
| Diagnosis | PBS Findings |
|---|---|
| Thalassaemia major | Microcytic hypochromic anaemia, target cells, nucleated RBCs, basophilic stippling, tear-drop cells, Cabot rings |
| Hereditary spherocytosis | Spherocytes (small, round, dense cells without central pallor), elevated MCHC |
| Sickle cell anaemia | Sickle cells, target cells, Howell-Jolly bodies (asplenic), irreversibly sickled cells |
| Malaria | Plasmodium species within RBCs (ring forms, trophozoites, schizonts, gametocytes) |
| Kala-azar (visceral leishmaniasis) | Pancytopenia; LD bodies in monocytes/macrophages (rare in PBS, better on bone marrow) |
| Acute Leukaemia (ALL) | Blast cells (lymphoblasts), anaemia, thrombocytopenia, leukocytosis or leukopenia |
| Autoimmune haemolytic anaemia | Spherocytes, polychromasia, nucleated RBCs |
| Gaucher's disease | Pancytopenia (hypersplenism); Gaucher cells (crinkled tissue paper) in bone marrow, not PBS |
| Diagnosis | USG Findings |
|---|---|
| Portal hypertension (EHPVO) | Cavernous transformation of portal vein, splenomegaly, collaterals, normal liver echotexture |
| Cirrhosis | Shrunken, echogenic liver with irregular surface, splenomegaly, ascites, dilated portal vein (>13 mm) |
| Kala-azar | Massive splenomegaly, homogeneous spleen, mild hepatomegaly |
| Thalassaemia | Hepatosplenomegaly, increased liver echogenicity (iron overload/haemosiderosis) |
| Storage disorders | Hepatosplenomegaly, diffusely hyperechoic liver (lipid/glycogen deposition) |
| Budd-Chiari syndrome | Absent/reversed hepatic venous flow, caudate lobe hypertrophy, ascites |
| Hepatic haemangioma | Hyperechoic lesion with peripheral enhancement |
Gold standard: Demonstration of LD bodies (Leishman-Donovan bodies = amastigotes) in:
- Splenic aspirate — highest sensitivity (~98%), but risk of bleeding
- Bone marrow aspirate — safer, sensitivity ~70-80%
- Liver biopsy, lymph node aspirate (lower yield)
Serological tests:
- rK39 RDT (ICT/rapid card test) — high sensitivity and specificity, widely used in field settings, Indian subcontinent
- DAT (Direct Agglutination Test) — sensitive and specific, used in resource-limited settings
- ELISA for anti-Leishmania antibodies
PCR: Most sensitive, detects low parasite loads, useful in immunocompromised patients.
Aldehyde/formol-gel test (Chopra's) — old, non-specific, no longer recommended.
- Suspected leukaemia or lymphoma (blast cells on PBS, pancytopenia)
- Suspected kala-azar (LD bodies in BM)
- Suspected storage disorder (Gaucher cells — "crinkled tissue paper" appearance; Niemann-Pick — foam cells/sea-blue histiocytes)
- Haemophagocytic lymphohistiocytosis (HLH) — haemophagocytosis in BM
- Unexplained pancytopenia
- Miliary TB — granulomas in BM
- Neuroblastoma — tumour cell infiltration
| Storage Disorder | Diagnostic Test |
|---|---|
| Gaucher's disease | ↓ β-glucocerebrosidase (glucosylceramidase) in leukocytes; elevated plasma chitotriosidase; Gaucher cells in BM |
| Niemann-Pick disease (Type A/B) | ↓ Sphingomyelinase activity in leukocytes; foam cells (sea-blue histiocytes) in BM |
| Glycogen Storage Disease (Type I) | ↓ Glucose-6-phosphatase in liver biopsy; hypoglycaemia, hyperlipidaemia, hyperuricaemia |
| Mucopolysaccharidoses (e.g., Hurler's) | ↑ Urinary glycosaminoglycans; specific enzyme assay (e.g., ↓α-L-iduronidase); coarse facial features, corneal clouding |
| Wilson's disease | ↓ Serum ceruloplasmin; ↑ 24-h urine copper; Kayser-Fleischer rings on slit-lamp; liver biopsy copper quantification |
- Chest X-ray (PA view): Miliary mottling in TB; cardiomegaly in CCF; pleural effusion in hypoalbuminaemia/cirrhosis
- Skull X-ray (lateral view): Hair-on-end appearance (diploë expansion due to extramedullary haematopoiesis) in thalassaemia; "Crew-cut" appearance
- Long bone X-rays: Erlenmeyer flask deformity of distal femur (failure of normal bone modelling) in Gaucher's disease and osteopetrosis
- USG abdomen + Doppler: First-line imaging for all cases of HSM (organ size, liver architecture, portal flow, ascites)
- CT Abdomen: Hepatic masses, biliary anatomy, abdominal lymphadenopathy, splenic infarcts
- MRI Liver (T2* / GRE sequences): Assessment of hepatic iron overload (haemosiderosis) in thalassaemia — non-invasive alternative to liver biopsy
- MRI Brain + Spine: For neurological complications of Wilson's disease, storage disorders
- Endoscopy (OGD): To detect oesophageal/gastric varices in portal hypertension
| Pattern | Significance |
|---|---|
| ↑ Indirect bilirubin + ↑ reticulocyte count + ↓ Hb + normal LFTs | Haemolytic anaemia (thalassaemia, spherocytosis) |
| ↑ Direct + indirect bilirubin + ↑ ALT/AST + normal ALP | Hepatocellular disease (hepatitis, Wilson's disease) |
| ↑ ALP + ↑ GGT + ↑ Direct bilirubin with normal ALT/AST | Cholestatic/obstructive cause (biliary atresia, choledochal cyst, primary sclerosing cholangitis) |
| ↓ Albumin + ↑ PT/INR + deranged all LFTs | Chronic liver disease / liver failure |
| ↑ ALT/AST with near-normal bilirubin | Early hepatitis, Wilson's disease |
| Normal LFTs + massive splenomegaly | EHPVO (portal hypertension with preserved liver function), haemolytic anaemia, kala-azar |
| ↑ Alpha-fetoprotein (AFP) | Hepatoblastoma, hepatocellular carcinoma, neonatal hepatitis |
💊 Management — Exam Q&A
1. Regular Blood Transfusions: Maintain pre-transfusion Hb ≥ 9–10 g/dL (hypertransfusion regimen). Suppresses ineffective erythropoiesis, reduces bone deformities and extramedullary haematopoiesis, reduces splenomegaly.
2. Iron Chelation Therapy: Mandatory to prevent iron overload (haemosiderosis).
- Desferrioxamine (DFO) — subcutaneous infusion 8–12 hours/day, 5–6 nights/week
- Deferasirox (oral) — 20–40 mg/kg/day — more convenient, widely used
- Deferiprone (oral) — especially useful for cardiac iron; used in combination with DFO
3. Splenectomy: Indicated when packed cell requirement exceeds 250 mL/kg/year. Delay until age ≥5 years to reduce infection risk. Must immunise with pneumococcal, meningococcal, and Hib vaccines ≥14 days before splenectomy. Lifelong penicillin prophylaxis post-splenectomy.
4. Curative: Haematopoietic Stem Cell Transplantation (HSCT) — the only cure. Best results with HLA-matched sibling donor before significant iron overload.
Drug of choice (India — National Programme):
- Liposomal Amphotericin B (AmBisome) — 3–5 mg/kg/day IV for 3–5 days (single dose regimen: 10 mg/kg IV as single infusion also used in India). Safe and highly effective (>95% cure rate). Drug of choice in pregnancy, renal disease.
Other options:
- Miltefosine (oral) — 2.5 mg/kg/day × 28 days. Not recommended in pregnancy. Emerging resistance in India.
- Conventional Amphotericin B deoxycholate — IV 0.75–1 mg/kg/day every alternate day × 15 doses. Effective but more nephrotoxic.
- Meglumine antimoniate / Sodium stibogluconate — pentavalent antimonials, now largely abandoned in India due to high resistance.
Supportive: Nutritional support, treat secondary infections. Splenomegaly and hepatomegaly regress with treatment over months.
Management of Acute Variceal Bleeding:
- IV access, resuscitation, blood transfusion (maintain Hb ~8 g/dL — avoid over-transfusion)
- Terlipressin (vasopressin analogue) or Octreotide — reduce portal pressure
- Endoscopic variceal ligation (EVL) or endoscopic sclerotherapy — to control acute bleed
- Antibiotics (ceftriaxone) — reduce risk of bacterial peritonitis
- Sengstaken-Blakemore tube — temporary tamponade if endoscopy unavailable
Secondary Prophylaxis (Prevention of Re-bleeding):
- Serial EVL or sclerotherapy until varices are eradicated
- Non-selective beta-blockers (propranolol) — for secondary prophylaxis (less commonly used in children)
- Meso-Rex shunt (Rex shunt) — surgical bypass between superior mesenteric vein and left portal vein (intrahepatic). Preferred definitive surgery in EHPVO as it restores physiological portal flow to the liver.
- Distal splenorenal shunt / portocaval shunts — alternative if Rex shunt not feasible
Indications for splenectomy:
- Thalassaemia major — transfusion requirement > 250 mL/kg/year of packed RBCs
- Hereditary spherocytosis — moderate/severe disease with significant haemolysis
- Chronic ITP — refractory to steroids/IV Ig
- Hypersplenism with severe cytopenias
- Symptomatic massive splenomegaly (pain, early satiety)
- Splenic trauma with uncontrolled haemorrhage
Precautions (OPSI — Overwhelming Post-Splenectomy Infection):
- Delay splenectomy until ≥5 years of age whenever possible
- Immunise ≥14 days before: Pneumococcal vaccine, Meningococcal vaccine, Hib vaccine
- Annual influenza vaccine
- Lifelong oral penicillin prophylaxis (or amoxicillin)
- Educate parents regarding fever — any febrile illness requires urgent medical attention (risk of fulminant sepsis with encapsulated organisms: Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis)
- Enzyme Replacement Therapy (ERT): The mainstay of treatment for Type 1 and Type 3 Gaucher's disease.
- Imiglucerase (Cerezyme) — IV infusion every 2 weeks. Reduces hepatosplenomegaly, improves bone disease and haematological parameters.
- Velaglucerase alfa (VPRIV), Taliglucerase alfa (Elelyso) — alternative ERT agents
- Substrate Reduction Therapy (SRT):
- Miglustat — oral; used when ERT is not available or tolerated (Type 1)
- Eliglustat — oral; for adult Type 1 (pharmacogenomics-guided)
- Type 2 (acute neuronopathic): No effective therapy; fatal in early childhood
- HSCT: Experimental; ERT is preferred
ERT does not cross the blood-brain barrier, so neurological manifestations (Type 3) have limited response.
- D-Penicillamine — copper chelator; first-line for hepatic Wilson's disease; 20 mg/kg/day. Side effects: lupus-like syndrome, haematological toxicity, nephrotoxicity.
- Trientine (Triethylene tetramine) — alternative to D-penicillamine, fewer side effects; used in intolerance or neurological disease.
- Zinc acetate/sulfate — induces metallothionein in intestinal cells → reduces copper absorption. Used for maintenance, pre-symptomatic children, and in pregnancy.
- Low copper diet: Avoid organ meats, shellfish, nuts, chocolate, mushrooms.
- Liver transplantation: For acute liver failure (Wilson's crisis), decompensated cirrhosis unresponsive to chelation, or aplastic anaemia.
- Splenic sequestration crisis (particularly in sickle cell disease, thalassaemia) — large volume of blood trapped in spleen → sudden ↓ Hb → hypovolemic shock → Emergency blood transfusion
- Splenic rupture — spontaneous or following minor trauma; abdominal pain, haemorrhagic shock → Emergency surgery
- Splenic infarction — severe left-sided pain → analgesia, manage underlying cause
- Variceal bleeding (portal hypertension) → IV terlipressin/octreotide + endoscopic intervention
- Hypersplenism → severe thrombocytopenia → bleeding risk → treat underlying cause ± splenectomy
🔭 Recent Advances — Exam Q&A
- Haematopoietic Stem Cell Transplantation (HSCT): Best results with matched sibling donor before age 7, Pesaro Class I/II. Improving outcomes with unrelated/mismatched donors using reduced-intensity conditioning (RIC).
- Gene Therapy (Betibeglogene Spartarvec — Zynteglo™): FDA-approved (2022) for transfusion-dependent thalassaemia. Patient's own stem cells are modified with lentiviral vector to produce functional haemoglobin (HbAT87Q). Eliminates transfusion dependence in most patients.
- CRISPR-Cas9 gene editing (Exa-cel — Casgevy™): FDA-approved (2023) for thalassaemia and sickle cell disease. Reactivates fetal haemoglobin (HbF) production by disrupting BCL11A gene → ↑ HbF → functional haemoglobin compensation. Revolutionary — potential one-time cure.
- Luspatercept (Reblozyl): Erythroid maturation agent (TGF-β ligand trap). Reduces transfusion burden in adults; under study in children with thalassaemia.
- Diagnosis: Loop-mediated isothermal amplification (LAMP) — rapid, field-deployable PCR alternative. High sensitivity/specificity, does not require cold chain or sophisticated equipment.
- Single-dose Liposomal Amphotericin B: WHO-recommended regimen for Indian subcontinent — 10 mg/kg single IV infusion. >95% cure rate, simplified treatment, reduces hospitalization.
- Combination therapy: Single-dose AmBisome + miltefosine being evaluated to prevent resistance and improve cure rates.
- Elimination Programme (India): India's National Kala-azar Elimination Programme target: incidence <1 per 10,000 population at block level. Indoor residual spraying (IRS) + vector control + active case detection are key pillars.
- Post Kala-azar Dermal Leishmaniasis (PKDL): Rash appearing months after VL treatment; macular/papular rash, especially face. Important reservoir for transmission. Treatment: Miltefosine 12 weeks, or liposomal Amphotericin B.
HLH is a life-threatening hyper-inflammatory syndrome caused by uncontrolled activation of T-cells and macrophages leading to haemophagocytosis (phagocytosis of blood cells by macrophages).
HLH-2004 Diagnostic Criteria (≥5 of 8):
- Fever (≥38.5°C)
- Splenomegaly
- Cytopenias (≥2 lineages): Hb <9 g/dL, platelets <100,000, neutrophils <1000
- Hypertriglyceridaemia (fasting TG ≥265 mg/dL) and/or hypofibrinogenaemia (≤1.5 g/L)
- Haemophagocytosis on BM/spleen/lymph node biopsy
- Low/absent NK cell activity
- ↑ Serum ferritin (≥500 μg/L; often >10,000 in HLH)
- Elevated soluble CD25 (sIL-2Rα) ≥2400 U/mL
Management (HLH-2004 Protocol):
- Dexamethasone (8–10 mg/m²/day) + Etoposide (150 mg/m² IV twice weekly) for 8 weeks
- Intrathecal methotrexate — for CNS disease
- Cyclosporine A — added in maintenance phase
- HSCT — for familial/primary HLH (essential for cure)
- Emapalumab (anti-interferon-γ antibody) — newer targeted therapy, FDA-approved for primary/refractory HLH
- Transient Elastography (FibroScan): Non-invasive measurement of liver stiffness using ultrasound shear-wave technique. Values correlate with degree of hepatic fibrosis. Replaces liver biopsy in many settings for monitoring fibrosis progression in NAFLD, hepatitis B/C, Wilson's, thalassaemia-related liver iron overload.
- MRI-based Liver Stiffness (MRE): More accurate than FibroScan; particularly useful in overweight children or where FibroScan quality is poor. MRI-PDFF (proton density fat fraction) for hepatic steatosis quantification in NAFLD.
- MRI-T2* / R2*: Gold-standard non-invasive quantification of hepatic iron concentration in thalassaemia (iron overload monitoring to guide chelation). T2* < 6.3 ms indicates severe iron overload (cardiac iron load can also be assessed).
- Serum biomarkers: APRI score (AST-to-platelet ratio index), FIB-4 index — simple scoring systems for fibrosis estimation in resource-limited settings.
⚡ Key Points — Quick Revision
One-Liners for Exam
- Hepatomegaly: Liver >3.5 cm below RCM in neonates; >2 cm in older children; always confirm by liver SPAN
- Most common cause of HSM overall: Infections (malaria, kala-azar, typhoid in endemic areas)
- Most common cause of HSM in thalassaemia belt: Thalassaemia major (extramedullary haematopoiesis)
- Massive splenomegaly mnemonic (KATT MSG): Kala-azar, Acute/chronic Malaria, Thalassaemia, TB, Myeloproliferative disorders, Spherocytosis/Sickle cell, Gaucher's
- Hackett's Grade V: Spleen in right iliac fossa
- Traube's space dullness: Suggests splenomegaly
- Thalassaemia facies: Frontal bossing, malar prominence, flat nasal bridge, prominent teeth ("chipmunk facies") — due to marrow expansion
- Hair-on-end / Crew-cut appearance on skull X-ray: Thalassaemia major (diploë expansion)
- Erlenmeyer flask deformity: Gaucher's disease (failure of bone modelling at metaphysis)
- Cherry-red spot on macula: Niemann-Pick Type A, Tay-Sachs, GM1 gangliosidosis
- KF rings: Wilson's disease (slit-lamp examination)
- Gold standard for kala-azar: Splenic aspirate for LD bodies; rK39 RDT for field diagnosis
- Drug of choice for kala-azar (India): Liposomal Amphotericin B (single dose 10 mg/kg)
- Splenectomy threshold in thalassaemia: >250 mL/kg/year packed RBC requirement
- Pre-splenectomy vaccines: Pneumococcal + Meningococcal + Hib — at least 14 days before surgery
- OPSI organisms: Streptococcus pneumoniae (most common), H. influenzae, N. meningitidis
- Preferred surgery for EHPVO: Rex shunt (Meso-Rex bypass)
- Curative treatment for thalassaemia: HSCT (matched sibling) OR Gene therapy (Zynteglo/Casgevy)
- Hypersplenism diagnosis (4 criteria): Splenomegaly + Peripheral cytopenia + Cellular BM + Resolution after splenectomy
- HLH hallmark investigations: Ferritin >10,000 + Haemophagocytosis on BM + Elevated soluble CD25
- Normal liver can be palpable in: Thin children, hyperinflated lungs, Riedel's lobe — always measure SPAN
🚨 High-Yield Differentiators
- HSM + normal LFTs + massive spleen: Think EHPVO, kala-azar, haemolytic anaemia — NOT liver disease
- HSM + jaundice + elevated indirect bilirubin: Haemolytic cause (thalassaemia, spherocytosis, autoimmune)
- HSM + elevated direct bilirubin + elevated ALP: Cholestatic cause (biliary atresia, PSC)
- HSM + delayed milestones + consanguinity: Storage disorder until proven otherwise
- Soft murmur/flow murmur in HSM: Due to hyperdynamic circulation from severe anaemia — not a cardiac lesion
- Caput medusae flow direction: AWAY from umbilicus (portal HT) vs. TOWARD umbilicus upward (IVC obstruction)